Michael Grabner

Adherence, persistence, glycaemic control and costs among patients with type 2 diabetes initiating dulaglutide compared with liraglutide or exenatide once weekly at 12‐month follow‐up in a real‐world setting in the United States

Reema Mody, Qing Huang, Maria Yu et al. · Diabetes Obesity and Metabolism · 2018 · 94 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Cardiovascular risk in patients achieving low-density lipoprotein cholesterol and particle targets

Peter P. Tóth, Michael Grabner, Rajeshwari Punekar et al. · Atherosclerosis · 2014 · 63 citations · Full text

Medicine, Cardiology, Clinical Epidemiology +16

Are patients on basal insulin attaining glycemic targets? Characteristics and goal achievement of patients with type 2 diabetes mellitus treated with basal insulin and physician-perceived barriers to achieving glycemic targets

Mehul Dalal, Michael Grabner, Nicole Bonine et al. · Diabetes Research and Clinical Practice · 2016 · 60 citations · Full text

Medicine, Endocrinology, Internal Medicine +17

Real-world effectiveness, adherence and persistence among patients with type 2 diabetes mellitus initiating dulaglutide treatment

Reema Mody, Michael Grabner, Maria Yu et al. · Current Medical Research and Opinion · 2017 · 51 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

BMI Trends, Socioeconomic Status, and the Choice of Dataset

Michael Grabner · Obesity Facts · 2012 · 42 citations · Full text

Public Health, Population Health Sciences, Public Health Nutrition +17